Profile data is unavailable for this security.
About the company
Guangdong Marubi Biotechnology Co Ltd is a China-based company principally engaged in the research, design, production, and sales of various cosmetics and related services. The Company’s products mainly include eye care products, skin cleansing products, skincare products, and beauty products. The Company's main brands include Marubi, Chunji, and Lianhuo. The Company mainly operates its businesses in the domestic market.
- Revenue in CNY (TTM)3.47bn
- Net income in CNY346.72m
- Incorporated2002
- Employees1.19k
- LocationGuangdong Marubi Biotechnology Co LtdNo.11 Xicun RoadZhujiang New City, Tianhe DistrictGUANGZHOU 510308ChinaCHN
- Phone+86 2 066378685
- Fax+86 2 066378600
- Websitehttps://www.marubi.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hangzhou Haoyue Personal Care Co Ltd | 3.61bn | 296.42m | 6.82bn | 1.76k | 23.03 | 2.01 | -- | 1.89 | 1.38 | 1.38 | 16.79 | 15.74 | 0.7323 | 6.45 | 12.94 | 2,050,366.00 | 6.02 | 11.53 | 8.36 | 15.28 | 29.76 | 27.90 | 8.22 | 16.35 | 1.26 | -- | 0.0745 | 35.00 | 6.25 | 8.44 | -11.65 | 4.21 | 16.00 | -- |
| Guangdong Marubi Biotechnology Co Ltd | 3.47bn | 346.72m | 13.23bn | 1.19k | 38.17 | 3.98 | -- | 3.82 | 0.8646 | 0.8646 | 8.65 | 8.29 | 0.7472 | 3.98 | 82.73 | 2,926,428.00 | 7.53 | 7.33 | 10.36 | 9.40 | 72.89 | 68.77 | 10.07 | 14.26 | 1.61 | -- | 0.1452 | 55.53 | 33.44 | 10.52 | 31.69 | -7.88 | 118.03 | 13.97 |
| Shanghai Jahwa United Co Ltd | 6.16bn | -590.47m | 15.00bn | 4.31k | -- | 2.13 | -- | 2.43 | -0.8912 | -0.8912 | 9.28 | 10.49 | 0.5679 | 3.62 | 7.89 | 1,429,630.00 | -5.44 | 2.10 | -7.41 | 2.85 | 59.65 | 57.80 | -9.58 | 3.58 | 1.57 | -- | 0.0822 | 56.20 | -13.93 | -5.65 | -266.60 | -- | -12.25 | -34.56 |
Data as of Feb 06 2026. Currency figures normalised to Guangdong Marubi Biotechnology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
5.27%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 11.51m | 2.87% |
| Bank of Communications Schroder Fund Management Co., Ltd.as of 30 Jun 2025 | 2.48m | 0.62% |
| HFT Investment Management Co., Ltd.as of 30 Jun 2025 | 2.37m | 0.59% |
| New China Fund Management Co., Ltd.as of 30 Jun 2025 | 991.40k | 0.25% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 943.00k | 0.24% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 799.89k | 0.20% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 715.42k | 0.18% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 521.10k | 0.13% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 427.00k | 0.11% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 388.80k | 0.10% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
